Zhengrui Xiao

What was reported, 2019–2025

$7,912

General payments

49 separate payments. What they were, as CMS records them, is below.

$0

Research payments

Funding for a study, usually paid to an institution with this doctor named on it. Not added to general payments, and not income.

$0

Ownership and investment

The value of a stake this doctor or an immediate family member held.

0

Disputed

This doctor has contested none of the payments reported about them.

How this compares

General payments: $7,912, 2019–⁠2025

By the amount companies reported, ranks 135,720th of 1,688,859 profiles with general payments nationally, 9,994th of 117,197 in New York and 3,745th of 11,988 in Hematology & Oncology. More than 91% of the 1,688,859 profiles with general payments nationally. It is < 0.1% of the $17,307,111,322 reported nationally.

What the payments were

Each payment as the manufacturer categorized it when reporting it to CMS, across 2019–2025. Together they are the general payments above. A category is the reporter’s, and nothing in the record says a payment in any of them was improper.

By program year

CMS reports a program year at a time and also publishes its own total across them, which is what the figures above are. These rows are that total taken apart, not a second set of payments.

CMS’s file covers 2019–2025. It holds no payments to Zhengrui Xiao in 2019–2022.

The record

National Provider Identifier

1689194904

The identifier this page is addressed by, and the one both CMS files share.

Specialty

Hematology & Oncology

Allopathic & Osteopathic Physicians, in CMS's taxonomy.

Licensed in

NY

The state of the license CMS lists first.

Recipient type

Covered Recipient Physician

How CMS classifies the recipient of these payments.

Medicare prescribing

What this provider billed to Medicare Part D in 2024, as CMS published it. Medicare Part D only: what they prescribed outside it is not here.

208

Claims

Prescriptions and refills billed to Part D, as CMS counts them.

$489,886

Total drug cost

What Part D, the plan and the patient paid together. Not what this provider was paid — they are paid nothing out of it.

46

Beneficiaries

People with at least one prescription from this provider.

116

Brand-name claims

Of the claims above, those for a brand-name drug.

92

Generic claims

Of the claims above, those for a generic.

not reported

Opioid claims

Claims for an opioid. CMS published no figure for this provider, and there is no suppression marker on this measure — so this is an absent figure rather than a withheld one, and it is not a zero.

not reported

Antibiotic claims

Claims for an antibiotic.

Medical Oncology

Prescriber type

As CMS classifies this prescriber. Credentials: MD.

A blank is not a zero. CMS withholds a value between 1 and 10, and withholds the next lowest alongside it so the first cannot be worked out by subtraction — so a withheld figure is not even evidence that the number was small. Rows for ten or fewer claims are removed from the file altogether, which is why the parts of a total can be withheld while the total is published.

Elsewhere

• Payments to doctors in New York — what was reported across the state this doctor practises in.
• What drug and device companies pay doctors — the national picture these figures are part of.
• This record at CMS — the publisher’s own page for this profile.
• The NPI registry — who this identifier belongs to, at CMS.